Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and Canine Diseases

9,10-dimethyl-1,2-benzanthracene has been researched along with Canine Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaturvedi, U; Desai, GS; Dhara, SK; Kumar, A; Kumar, GV; Kumar, S; Rajmani, RS; Sahoo, AP; Santra, L; Saxena, S; Singh, LV; Tiwari, AK1
Doi, K; Kawai, K; Nakayama, H; Uetsuka, K1

Other Studies

2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Canine Diseases

ArticleYear
Non-Structural protein 1 (NS1) gene of Canine Parvovirus-2 regresses chemically induced skin tumors in Wistar rats.
    Research in veterinary science, 2014, Volume: 97, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Carcinogens; Carcinoma, Squamous Cell; Disease Models, Animal; Dog Diseases; Dogs; Genetic Therapy; Male; Mitotic Index; Parvovirus, Canine; Rats; Rats, Wistar; Skin Neoplasms; Treatment Outcome; Viral Nonstructural Proteins

2014
The activity of matrix metalloproteinases (MMPS) and tissue inhibitors of metalloproteinases (TIMPs) in mammary tumors of dogs and rats.
    The Journal of veterinary medical science, 2006, Volume: 68, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenoma; Animals; Breast Neoplasms; Carcinoma; Dog Diseases; Dogs; Electrophoresis, Polyacrylamide Gel; Female; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinases

2006